Literature DB >> 31491538

Outpatient oxaliplatin desensitizations: A process improvement evaluation.

Sara Barmettler1, Anna Wolfson2, Nancy Yang2, Xiaoqing Fu3, Kimberly Blumenthal4, Aleena Banerji2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31491538      PMCID： PMC6878134          DOI： 10.1016/j.anai.2019.08.021

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  7 in total

1.  Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.

Authors:  Johnson T Wong; Morris Ling; Sarita Patil; Aleena Banerji; Aidan Long
Journal:  J Allergy Clin Immunol Pract       Date:  2013-11-01

2.  Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.

Authors:  Alberta L Wang; Sarita U Patil; Aidan A Long; Aleena Banerji
Journal:  Ann Allergy Asthma Immunol       Date:  2015-08-19       Impact factor: 6.347

3.  Developing an Interdisciplinary, Team-Based Quality Improvement Leadership Training Program for Clinicians: The Partners Clinical Process Improvement Leadership Program.

Authors:  Sandhya K Rao; Victoria Carballo; Brian M Cummings; Frederick Millham; Joseph O Jacobson
Journal:  Am J Med Qual       Date:  2016-05-16       Impact factor: 1.852

4.  Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.

Authors:  Marek L Kowalski; Ignacio Ansotegui; Werner Aberer; Mona Al-Ahmad; Mubeccel Akdis; Barbara K Ballmer-Weber; Kirsten Beyer; Miguel Blanca; Simon Brown; Chaweewan Bunnag; Arnaldo Capriles Hulett; Mariana Castells; Hiok Hee Chng; Frederic De Blay; Motohiro Ebisawa; Stanley Fineman; David B K Golden; Tari Haahtela; Michael Kaliner; Connie Katelaris; Bee Wah Lee; Joanna Makowska; Ulrich Muller; Joaquim Mullol; John Oppenheimer; Hae-Sim Park; James Parkerson; Giovanni Passalacqua; Ruby Pawankar; Harald Renz; Franziska Rueff; Mario Sanchez-Borges; Joaquin Sastre; Glenis Scadding; Scott Sicherer; Pongsakorn Tantilipikorn; James Tracy; Vera van Kempen; Barbara Bohle; G Walter Canonica; Luis Caraballo; Maximiliano Gomez; Komei Ito; Erika Jensen-Jarolim; Mark Larche; Giovanni Melioli; Lars K Poulsen; Rudolf Valenta; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2016-10-12       Impact factor: 4.084

5.  Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses.

Authors:  Chyh-Woei Lee; Ursula A Matulonis; Mariana C Castells
Journal:  Gynecol Oncol       Date:  2005-07-27       Impact factor: 5.482

6.  A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions.

Authors:  Sarita U Patil; Aidan A Long; Morris Ling; Michael T Wilson; Paul Hesterberg; Johnson T Wong; Aleena Banerji
Journal:  J Allergy Clin Immunol       Date:  2011-11-17       Impact factor: 10.793

7.  Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancer.

Authors:  Ilan Bruchim; Osnat Jarchowsky-Dolberg; Ami Fishman
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-10-22       Impact factor: 2.435
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.